Search for Clinical Trial Results

Sponsored By

Amyloid Neuropathies - 25 Studies Found

Status Study
Completed Study Name: Study of SOM0226 in Familial Amyloid Polyneuropathy
Condition: Familial Amyloid Polyneuropathy (FAP)
Date: 2014-07-09
Interventions: Drug: SOM0226 Oral
Completed Study Name: The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin
Condition: Transthyretin Familial Amyloid Polyneuropathy
Date: 2011-09-13
Interventions: Drug: tafamidis tafamidis meglumine 20 mg QD Other N
Completed Study Name: An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
Condition:
  • Familial Amyloid Polyneuropathy
  • ATTR-PN

Date: 2008-11-13
Interventions: Drug: Fx-1006A Fx-1006A 20mg soft gelatin capsule administered orally once daily (at the same time each
Not yet recruiting Study Name: Prevalence of Amyloidosis and Carpal Tunnel
Condition: Amyloid Neuropathy, Carpal Tunnel
Date: 2014-04-01
Completed Study Name: Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
Condition: Familial Amyloid Polyneuropathy
Date: 2006-12-06
Interventions:
  • Drug: Fx-1006A Fx-1006A 20mg o
Active, not recruiting Study Name: Efficacy and Safety of IONIS-TTR Rx in Familial Amyloid Polyneuropathy
Condition:
  • FAP
  • Familial Amyloid Polyneuropathy
  • Drug: IONIS-TTR Rx 300 mg IONI
Enrolling by invitation Study Name: Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)
Condition:
  • FAP
  • Familial Amyloid Polyneuropathy
  • Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP)
  • Tra
    Date: 2012-05-21
    Interventions: Other: No drug No drug.
Completed Study Name: The Effect of Diflunisal on Familial Amyloidosis
Condition:
  • Familial Amyloid Polyneuropathy
  • Familial Amyloidosis

Date: 2006-02-21
Interventions:
  • Drug: diflunisal given twice d
Completed Study Name: The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant
Condition:
  • Transthyretin (TTR)-Mediated Amyloidosis
  • Familial Amyloidotic Polyneuropathy (FAP)
  • Date: 2015-10-30
    Interventions: Drug: Revusiran (ALN-TTRSC) 500mg Revusiran by subcutaneous (sc) injection
Next >>>